This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Pharmaceutica Nv. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Jurzak Mirek: Innovator in Radiolabeled Compounds
Introduction
Jurzak Mirek is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of radiolabeled compounds. His work is characterized by a focus on innovative methods that enhance the efficacy of medical treatments.
Latest Patents
Mirek holds a patent for "Radiolabeled astemizole and method of making." This invention provides a radiolabeled astemizole of formula (III) and outlines a process for preparing this compound. The patent represents a significant advancement in the use of radiolabeled drugs for diagnostic and therapeutic purposes.
Career Highlights
Jurzak Mirek is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at Janssen has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug formulations.
Collaborations
Mirek has collaborated with esteemed colleagues such as Godelieve Irma Christine Maria Heylen and Cornelus Gerardus Maria Janssen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.
Conclusion
Jurzak Mirek's contributions to the field of radiolabeled compounds exemplify the impact of innovative thinking in pharmaceuticals. His work continues to influence the development of new medical treatments that benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile